Comparison of breakthrough Gram-positive cocci infection during vancomycin vs teicoplanin therapy in patients receiving haematopoietic stem cell transplantation.

Koichi OhataJunichi KitagawaTakashi NiwaTomoyo Takahashi-YamauchiSaki HaradaTakuro MatsumotoNobuhiko NakamuraHiroshi NakamuraNobuhiro KanemuraMasahito ShimizuAkio Suzuki

Published in: Journal of clinical pharmacy and therapeutics (2020)

The incidence of breakthrough GPC infection during glycopeptide therapy in febrile neutropenic HSCT patients was higher in the TEIC group than in the VCM group. MR-S haemolyticus with low glycopeptide susceptibility was isolated from all patients with breakthrough GPC infection and successfully treated with DAP.

Keyphrases

stem cell transplantation
high dose
end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
peritoneal dialysis
magnetic resonance
gram negative
stem cells
magnetic resonance imaging
computed tomography
low dose
multidrug resistant
contrast enhanced
cell therapy